An NCI- Designated Cancer Center
The Dan L. Duncan Cancer Center at Baylor College of Medicine is a consortium made up of several institutions across the Texas Medical Center. The Duncan Cancer Center at BCM brings together all of the cancer-related activities from across these institutions under one umbrella, fast-tracking our efforts to prevent and ultimately cure cancer in all its forms.
Center for Cell and Gene Therapy receives renewed NIH funding to enhance T cell therapy for cancer
Researchers from the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine have received a $11.3 million renewal grant from the National Institutes of Health to advance the development of more effective and less toxic targeted T cell therapies for children and adults with cancer.
Center for Cell and Gene Therapy members Dr. Helen Heslop, professor of medicine and pediatrics - hematology-oncology at BCM and director of the Adult Stem Cell Transplant Program at The Methodist Hospital, and Dr. Cliona Rooney, a professor of pediatrics - hematology-oncology, molecular virology and microbiology and of immunology at BCM, serve as co-principal investigators of the project. Heslop and Rooney are also members of the NCI-designated Dan L. Duncan Cancer Center at BCM.
Coming Soon! Dan L. Duncan Cancer Center’s Forte OnCore® Clinical Trials Management System Roll-out